609 related articles for article (PubMed ID: 26621348)
21. Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors.
Bhimani RV; Vik M; Wakabayashi KT; Szalkowski C; Bass CE; Park J
J Neurochem; 2021 Aug; 158(4):865-879. PubMed ID: 34265079
[TBL] [Abstract][Full Text] [Related]
22. Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.
Meyer AC; Neugebauer NM; Zheng G; Crooks PA; Dwoskin LP; Bardo MT
J Neurochem; 2013 Oct; 127(2):187-98. PubMed ID: 23875705
[TBL] [Abstract][Full Text] [Related]
23. Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes.
Yorgason JT; Hedges DM; Obray JD; Jang EY; Bills KB; Woodbury M; Williams B; Parsons MJ; Andres MA; Steffensen SC
Psychopharmacology (Berl); 2020 May; 237(5):1317-1330. PubMed ID: 31965252
[TBL] [Abstract][Full Text] [Related]
24. A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference.
Niwa M; Nitta A; Mizoguchi H; Ito Y; Noda Y; Nagai T; Nabeshima T
J Neurosci; 2007 Jul; 27(28):7604-15. PubMed ID: 17626222
[TBL] [Abstract][Full Text] [Related]
25. Methamphetamine induces Shati/Nat8L expression in the mouse nucleus accumbens via CREB- and dopamine D1 receptor-dependent mechanism.
Uno K; Miyazaki T; Sodeyama K; Miyamoto Y; Nitta A
PLoS One; 2017; 12(3):e0174196. PubMed ID: 28319198
[TBL] [Abstract][Full Text] [Related]
26. Dopamine D
Tu G; Ying L; Ye L; Zhao J; Liu N; Li J; Liu Y; Zhu M; Wu Y; Xiao B; Guo H; Guo F; Wang H; Zhang L; Zhang L
Biol Psychiatry; 2019 Dec; 86(11):820-835. PubMed ID: 31060803
[TBL] [Abstract][Full Text] [Related]
27. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
[TBL] [Abstract][Full Text] [Related]
28. Nucleus accumbens dopamine and mu-opioid receptors modulate the reinstatement of food-seeking behavior by food-associated cues.
Guy EG; Choi E; Pratt WE
Behav Brain Res; 2011 Jun; 219(2):265-72. PubMed ID: 21262268
[TBL] [Abstract][Full Text] [Related]
29. Administration of activated glial condition medium in the nucleus accumbens extended extinction and intensified reinstatement of methamphetamine-induced conditioned place preference.
Arezoomandan R; Moradi M; Attarzadeh-Yazdi G; Tomaz C; Haghparast A
Brain Res Bull; 2016 Jul; 125():106-16. PubMed ID: 27346277
[TBL] [Abstract][Full Text] [Related]
30. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.
Churchill L; Kalivas PW
Synapse; 1992 May; 11(1):47-57. PubMed ID: 1318584
[TBL] [Abstract][Full Text] [Related]
31. Integrative opioid-GABAergic neuronal mechanisms regulating dopamine efflux in the nucleus accumbens of freely moving animals.
Saigusa T; Aono Y; Waddington JL
Pharmacol Rep; 2021 Aug; 73(4):971-983. PubMed ID: 33743175
[TBL] [Abstract][Full Text] [Related]
32. Familiar companions diminish cocaine conditioning and attenuate cocaine-stimulated dopamine release in the nucleus accumbens.
Tzeng WY; Cherng CF; Wang SW; Yu L
Behav Brain Res; 2016 Jun; 306():146-53. PubMed ID: 27001454
[TBL] [Abstract][Full Text] [Related]
33. Mice deficient in protein tyrosine phosphatase receptor type Z (PTPRZ) show reduced responsivity to methamphetamine despite an enhanced response to novelty.
Fujikawa A; Noda Y; Yamamoto H; Tanga N; Sakaguchi G; Hattori S; Song WJ; Sora I; Nabeshima T; Katsuura G; Noda M
PLoS One; 2019; 14(8):e0221205. PubMed ID: 31430310
[TBL] [Abstract][Full Text] [Related]
34. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
Klitenick MA; Kalivas PW
J Pharmacol Exp Ther; 1994 Apr; 269(1):437-48. PubMed ID: 8169850
[TBL] [Abstract][Full Text] [Related]
35. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens.
Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193
[TBL] [Abstract][Full Text] [Related]
36. Regulatory system of mGluR group II in the nucleus accumbens for methamphetamine-induced dopamine increase by the medial prefrontal cortex.
Haddar M; Uno K; Hamatani K; Muramatsu SI; Nitta A
Neuropsychopharmacol Rep; 2019 Sep; 39(3):209-216. PubMed ID: 31283871
[TBL] [Abstract][Full Text] [Related]
37. Acupuncture inhibition of methamphetamine-induced behaviors, dopamine release and hyperthermia in the nucleus accumbens: mediation of group II mGluR.
Kim NJ; Ryu Y; Lee BH; Chang S; Fan Y; Gwak YS; Yang CH; Bills KB; Steffensen SC; Koo JS; Jang EY; Kim HY
Addict Biol; 2019 Mar; 24(2):206-217. PubMed ID: 29363229
[TBL] [Abstract][Full Text] [Related]
38. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.
Narita M; Matsushima Y; Niikura K; Narita M; Takagi S; Nakahara K; Kurahashi K; Abe M; Saeki M; Asato M; Imai S; Ikeda K; Kuzumaki N; Suzuki T
Addict Biol; 2010 Oct; 15(4):434-47. PubMed ID: 20731628
[TBL] [Abstract][Full Text] [Related]
39. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.
Hipólito L; Sánchez-Catalán MJ; Zanolini I; Polache A; Granero L
Neuropharmacology; 2008 Aug; 55(2):183-9. PubMed ID: 18582908
[TBL] [Abstract][Full Text] [Related]
40. Nucleus accumbens μ-opioid receptors mediate social reward.
Trezza V; Damsteegt R; Achterberg EJ; Vanderschuren LJ
J Neurosci; 2011 Apr; 31(17):6362-70. PubMed ID: 21525276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
